These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22965036)

  • 1. Biotechs opt for alternative floatation strategy.
    Ratner M
    Nat Biotechnol; 2012 Sep; 30(9):814. PubMed ID: 22965036
    [No Abstract]   [Full Text] [Related]  

  • 2. Russia becomes attractive as a source of IP for biotechs.
    Katsnelson A
    Nat Biotechnol; 2004 Sep; 22(9):1060. PubMed ID: 15340454
    [No Abstract]   [Full Text] [Related]  

  • 3. The public-private structure of intellectual property ownership in agricultural biotechnology.
    Graff GD; Cullen SE; Bradford KJ; Zilberman D; Bennett AB
    Nat Biotechnol; 2003 Sep; 21(9):989-95. PubMed ID: 12949559
    [No Abstract]   [Full Text] [Related]  

  • 4. The scope of utility in the twenty-first century: new guidance for gene-related patents.
    Summers TM
    Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
    [No Abstract]   [Full Text] [Related]  

  • 5. Physician proposals could cost biotechs thousands.
    Robertson D
    Nat Biotechnol; 2000 Jul; 18(7):707. PubMed ID: 10888827
    [No Abstract]   [Full Text] [Related]  

  • 6. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
    Hoffman DC
    Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
    [No Abstract]   [Full Text] [Related]  

  • 7. [Federal judge and government of the United States against gene patenting].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2011; 27(6-7):662-6. PubMed ID: 21718652
    [No Abstract]   [Full Text] [Related]  

  • 8. BIO marches to Congress with growth package in hand.
    Carey K
    Nat Biotechnol; 2011 Sep; 29(9):776-7. PubMed ID: 21904306
    [No Abstract]   [Full Text] [Related]  

  • 9. Chinese biotechs wrestle with transparency, cultural hurdles.
    Jia H; Tang F; Orelli B
    Nat Biotechnol; 2011 May; 29(5):377-8. PubMed ID: 21552225
    [No Abstract]   [Full Text] [Related]  

  • 10. Korean biotechs seize opportunity to list on public markets.
    Louët S
    Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 13. Western biotechs ponder follow-on possibilities.
    Waltz E
    Nat Biotechnol; 2008 Sep; 26(9):962-3. PubMed ID: 18779793
    [No Abstract]   [Full Text] [Related]  

  • 14. Cash-strapped biotechs find financing alternative.
    Mitchell P
    Nat Biotechnol; 2004 Sep; 22(9):1057-8. PubMed ID: 15340452
    [No Abstract]   [Full Text] [Related]  

  • 15. A lifeline for the biotech sector.
    Kessel M
    Nat Biotechnol; 2009 Feb; 27(2):123-4. PubMed ID: 19204686
    [No Abstract]   [Full Text] [Related]  

  • 16. Clusters in Industrial Biotechnology and Bioeconomy: The Roles of the Public Sector.
    Philp J; Winickoff DE
    Trends Biotechnol; 2017 Aug; 35(8):682-686. PubMed ID: 28487123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investing in risk management.
    Fiscus PW
    Nat Biotechnol; 1997 Jan; 15(1):88-9. PubMed ID: 9035113
    [No Abstract]   [Full Text] [Related]  

  • 18. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The legacy of nuclear risk and the founder effect in biotechnology organizations.
    Fleising U
    Trends Biotechnol; 2002 Apr; 20(4):156-9. PubMed ID: 11906747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public biotech 2011--the numbers.
    Huggett B; Lähteenmaki R
    Nat Biotechnol; 2012 Aug; 30(8):751-7. PubMed ID: 22871710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.